Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration
CLINICAL AND EXPERIMENTAL OPTOMETRY, cilt.105, sa.1, ss.55-60, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 105 Sayı: 1
- Basım Tarihi: 2022
- Doi Numarası: 10.1080/08164622.2021.1896334
- Dergi Adı: CLINICAL AND EXPERIMENTAL OPTOMETRY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.55-60
- Anahtar Kelimeler: Aflibercept, central macular thickness, neovascular age-related macular degeneration, ranibizumab, subfoveal choroidal thickness
- Çukurova Üniversitesi Adresli: Evet
Özet
Background: The aim of this study is to analyse the real-world outcome of vascular endothelial growth factor blocking agents in neovascular age-related macular degeneration.